SGMT Exercise Disclosure
Kemble George · SEC Form 4 · Filed Aug 12, 2026
Exercise
Calculated transaction value
$0
Kemble George Director
SGMT
Transaction date
Aug 11, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 1 day later
SGMT daily price context
Close on/before transaction
$9.52
Aug 11, 2026
Close before public filing
$9.52
Aug 11, 2026
Return since public filing
+16.49%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Series A Common Stock
- Quantity / price
- 10,455 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-347407
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$329.66K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Sagimet Biosciences Inc. SGMT | Exercise | Aug 11, 2026 | $62.02K |
| Sagimet Biosciences Inc. SGMT | Exercise | Aug 11, 2026 | $0 |
| Sagimet Biosciences Inc. SGMT | Sale | Aug 11, 2026 | $201.15K |
| Sagimet Biosciences Inc. SGMT Current | Exercise | Aug 11, 2026 | $0 |
| Sagimet Biosciences Inc. SGMT | Exercise | Aug 11, 2026 | $66.49K |